a life sciences company which engages in the development of nucleic acid (DNA)-based technologies to minimize rejection of transplanted organs by human recipients as well as address autoimmune diseases and allergies
Industry Biotechnology
A.I.dvisor tells us that ADTX and ORMP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADTX and ORMP's prices will move in lockstep.
Ticker / NAME | Correlation To ADTX | 1D Price Change % | ||
---|---|---|---|---|
ADTX | 100% | -4.25% | ||
ORMP - ADTX | 32% Poorly correlated | +2.21% | ||
NRBO - ADTX | 31% Poorly correlated | -2.08% | ||
CSCI - ADTX | 28% Poorly correlated | +0.31% | ||
XTLB - ADTX | 27% Poorly correlated | +3.39% | ||
BDRX - ADTX | 25% Poorly correlated | +14.29% | ||
More |